Overview

RDEA3170 Tablet and Capsule Bioavailability Study

Status:
Completed
Trial end date:
2016-01-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the relative bioavailability of RDEA3170 capsules compared with RDEA3170 tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Ardea Biosciences, Inc.
Treatments:
Verinurad